SBIO:ARCA-ALPS Medical Breakthroughs (USD)

ETF | Health | NYSE Arca

Last Closing

USD 33.81

Change

-0.01 (-0.03)%

Market Cap

USD 0.12B

Volume

9.04K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks total return, with an emphasis on income as the source of that total return. The fund seeks to achieve its investment objective by investing in a global portfolio of fixed income securities of various maturities, ratings and currency denominations. The adviser intends to utilize various investment strategies in a broad array of fixed income sectors. The fund may purchase fixed income securities issued by U.S. or foreign corporations or financial institutions, including debt securities of all types and maturities, convertible securities and preferred stocks. It is non-diversified.

Inception Date: 30/12/2014

Primary Benchmark: Poliwogg Medical Breakthroughs TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.5%

Management Expense Ratio: 0.50 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.75 (+0.54%)

USD 36.67B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.65 (+0.99%)

USD 2.62B
FXH First Trust Health Care AlphaD.. 0.63 %

+0.16 (+0.15%)

USD 1.09B
BBH VanEck Biotech ETF 0.35 %

-0.25 (-0.16%)

USD 0.42B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

-0.26 (-0.29%)

USD 0.21B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.15 (+0.66%)

USD 0.12B
XHS SPDR® S&P Health Care Service.. 0.35 %

-0.09 (-0.10%)

USD 0.07B
HTEC Robo Global® Healthcare Techn.. 0.00 %

+0.09 (+0.29%)

USD 0.05B
BBP Virtus LifeSci Biotech Product.. 0.79 %

+0.23 (+0.38%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

+0.16 (+0.64%)

USD 0.01B

ETFs Containing SBIO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.64% 55% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.64% 41% F 34% F
Trailing 12 Months  
Capital Gain 5.64% 73% C 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.64% 73% C 44% F
Trailing 5 Years  
Capital Gain -22.67% 14% F 25% F
Dividend Return 0.16% 15% F N/A F
Total Return -22.50% 14% F 15% F
Average Annual (5 Year Horizon)  
Capital Gain 0.38% 29% F 33% F
Dividend Return 0.43% 29% F 23% F
Total Return 0.05% 16% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 28.34% 29% F 38% F
Risk Adjusted Return 1.52% 29% F 21% F
Market Capitalization 0.12B 45% F 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.